Genentech boosted by Rituxan cancer drug
Genentech, one of the world's largest biotechnology groups, posted results of the quarter ended March 31 in line with expectations thanks to a strong performance by its cancer drug Rituxan. The
Genentech, one of the world's largest biotechnology groups, posted results of the quarter ended March 31 in line with expectations thanks to a strong performance by its cancer drug Rituxan. The